SEC Filing Details

Document Details

Form
Filing Date
Dec 06, 2023
Document Date
Dec 04, 2023
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
EyePoint Pharmaceuticals
Issuer
EYEPOINT PHARMACEUTICALS, INC.
Filer
Cormorant Asset Management, LP